Merck KGaA (FRA:MRK)

Market Cap	50.39B
Revenue (ttm)	21.32B
Net Income (ttm)	2.82B
Shares Out	n/a
EPS (ttm)	6.48
PE Ratio	17.88
Forward PE	12.94
Dividend	2.20 (1.91%)
Ex-Dividend Date	Apr 28, 2025

Volume	n/a
Average Volume	736
Open	115.25
Previous Close	114.80
Day's Range	115.25 - 116.70
52-Week Range	108.00 - 176.50
Beta	n/a
RSI	47.36
Earnings Date	May 15, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 59,020
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MRK

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.